kneat.com, inc. (TSE:KSI – Free Report) – Analysts at Stifel Canada raised their FY2024 earnings per share (EPS) estimates for shares of kneat.com in a research note issued on Tuesday, November 12th. Stifel Canada analyst J. Keywood now expects that the company will post earnings per share of ($0.13) for the year, up from their previous forecast of ($0.15). The consensus estimate for kneat.com’s current full-year earnings is ($0.12) per share. Stifel Canada also issued estimates for kneat.com’s Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.11) EPS.
Other research analysts have also recently issued reports about the company. Cibc World Mkts upgraded kneat.com to a “strong-buy” rating in a research report on Tuesday, October 29th. Ventum Cap Mkts upgraded shares of kneat.com to a “strong-buy” rating in a report on Wednesday, August 7th. Finally, CIBC set a C$6.00 target price on kneat.com and gave the company an “outperform” rating in a research report on Tuesday, October 29th.
kneat.com Trading Down 0.8 %
TSE:KSI opened at C$5.00 on Friday. The firm has a fifty day simple moving average of C$4.78 and a 200-day simple moving average of C$4.53. The company has a market capitalization of C$430 million, a P/E ratio of -31.25, a PEG ratio of 597.67 and a beta of 1.08. kneat.com has a 12 month low of C$2.80 and a 12 month high of C$5.17. The company has a current ratio of 1.47, a quick ratio of 1.50 and a debt-to-equity ratio of 95.14.
kneat.com Company Profile
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.
See Also
- Five stocks we like better than kneat.com
- Options Trading – Understanding Strike Price
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Use the MarketBeat Dividend Calculator
- Top-Performing Non-Leveraged ETFs This Year
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for kneat.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for kneat.com and related companies with MarketBeat.com's FREE daily email newsletter.